DANYELZA (Naxitamab) — NDC 73042-201 by Y-mAbs Therapeutics, Inc.
DANYELZA (Naxitamab) — NDC 73042-201 by Y-mAbs Therapeutics, Inc. is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: DANYELZA; Generic name: Naxitamab; Product NDC: 73042-201.
| Brand name | DANYELZA |
|---|---|
| Generic name | Naxitamab |
| Product NDC | 73042-201 |
| Labeler | Y-mAbs Therapeutics, Inc. |
| Dosage form | INJECTION |
| Route | INTRAVENOUS |
| Active ingredients | NAXITAMAB 40 mg/10mL |
| Pharmacologic class | Glycolipid Disialoganglioside-directed Antibody Interactions [MoA], Glycolipid Disialoganglioside-directed Antibody [EPC] |
| Marketing category | BLA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →